mtm laboratories today announced that it has made two new clinical research appointments to augment the team developing screening and diagnostic assays based on mtm’s proprietary p16INK4a biomarker. Lisa Kaufman is heading Clinical Operations in the US while Petra Klement is leading Clinical Operations in Europe.
